Detalhe da pesquisa
1.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605003
2.
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
Ann Intern Med
; 174(5): 641-648, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587686
3.
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.
J Med Internet Res
; 24(6): e33446, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737449
4.
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 124(7): 1222-1230, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495600
5.
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 126(9): 1362, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256756
6.
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 124(10): 1746, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723402
7.
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.
EClinicalMedicine
; 69: 102485, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370537
8.
Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry.
Eur J Cancer
; 182: 132-143, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773402
9.
Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands.
J Immunother
; 46(5): 197-204, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103470
10.
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.
Eur J Cancer
; 167: 70-80, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395553
11.
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.
JCO Oncol Pract
; 18(10): e1611-e1620, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944229
12.
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.
JAMA Netw Open
; 4(9): e2124766, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34505885
13.
Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status.
Am J Clin Oncol
; 44(2): 82-89, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332931
14.
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
Cancers (Basel)
; 13(20)2021 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680228
15.
Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
Eur J Cancer
; 158: 234-245, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34600790
16.
An invisible group of COVID-19 victims; impact on Dutch lung cancer care.
Lung Cancer
; 159: 177-178, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34303539